Dermatology Global Market Report 2025

The dermatology market size has grown strongly in recent years. It will grow from $1.38 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth observed during the historic period can be attributed to the rising prevalence of skin disorders, greater awareness of skin health, an increase in aesthetic and cosmetic procedures, an expanding aging population, improved access to dermatology care, and a higher demand for over-the-counter skincare products.

The dermatology market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be driven by the continued rise in skin disorders, growing awareness of skin health, the expansion of aesthetic and cosmetic procedures, the aging population, better access to dermatology care, and increased demand for over-the-counter skincare products. Key trends expected in the forecast period include the adoption of AI-powered diagnostic tools, advancements in tele dermatology, the development of personalized skincare treatments, the rise of non-invasive and laser-based procedures, innovations in biologics and immunotherapies, and progress in wearable devices for skin health monitoring.

The increasing prevalence of skin issues is expected to drive the growth of the dermatology market in the future. Skin problems refer to conditions that affect the skin's health, appearance, or function, such as irritation, inflammation, or infections. These issues are largely due to heightened exposure to environmental pollutants and UV radiation, both of which can damage the skin and lead to various conditions. Dermatology treats these skin problems using a mix of topical and oral medications, medical procedures, and lifestyle modifications tailored to each specific condition. For example, Cancer Australia reported in February 2025 that approximately 18,257 new cases of melanoma were diagnosed, accounting for 11% of all new cancer cases, along with 1,314 melanoma-related deaths, representing 2.6% of cancer deaths. As a result, the rising number of skin problems is fueling the growth of the dermatology market.

Leading companies in the dermatology market are focusing on innovations such as positioning sensors to ensure precise energy delivery during treatments, improving patient safety, and enhancing the effectiveness of dermatological procedures. Positioning sensors are technologies integrated into medical devices that track and adjust the device’s position to ensure accurate alignment and optimal energy delivery during treatments, thereby enhancing both treatment precision and patient safety. For instance, in June 2024, Biofrontera Inc. launched the RhodoLED XL Lamp, which improves the effectiveness of photodynamic therapy (PDT) by offering a larger illumination area, better patient positioning, and optimized energy delivery, setting a new standard for treating actinic keratoses. The device is designed for maneuverability and can accommodate various patient positions, making it easier for healthcare providers to optimize treatment. The positioning sensors are integrated to ensure that patients receive the correct energy dosage from the LED array, further enhancing treatment accuracy and safety.

In February 2025, Alkem Laboratories Limited, a pharmaceutical company based in India, acquired Adroit Biomed Ltd. for $0.0168 billion. This acquisition will help Alkem Laboratories diversify its portfolio, expand its market reach, strengthen its position in high-growth areas such as dermatology and cosmetology, and enhance its manufacturing capabilities. Adroit Biomed Ltd., also based in India, focuses on dermato-cosmetology.

Major players in the dermatology market are Pfizer Inc, Johnson And Johnson, Unilever Plc, AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, Novartis AG, Eli Lilly & Company, Amgen Inc., Bausch Health Companies Inc., UCB S.A, Galderma, Incyte Corporation, Dr. Reddy’s Laboratories, Zydus Healthcare Limited, Lupin Limited, LEO Pharma, Alkem Laboratories, Merz Therapeutics, Lumenis.

North America was the largest region in the dermatology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dermatology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dermatology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Dermatology is a branch of medicine focused on diagnosing and treating conditions related to the skin, hair, and nails, addressing both medical issues and cosmetic concerns.

The main branches of dermatology include medical dermatology, surgical dermatology, pediatric dermatology, cosmetic dermatology, cutaneous lymphoma, dermatoimmunology, and others. Medical dermatology involves diagnosing and treating a variety of skin conditions such as eczema, psoriasis, acne, and skin infections. Dermatological treatments are used for conditions such as acne, dermatitis, psoriasis, skin cancer, rosacea, alopecia, and more. These services are typically provided in hospitals, skin clinics, and other healthcare settings.

The dermatology market research report is one of a series of new reports that provides dermatology market statistics, including the dermatology industry global market size, regional shares, competitors with the dermatology market share, detailed dermatology market segments, market trends, and opportunities, and any further data you may need to thrive in the dermatology industry. This dermatology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dermatology market consists of revenues earned by entities by providing services such as hair and scalp treatments, phototherapy, tele dermatology, and allergy testing and treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The dermatology market also includes sales of topical creams, gels, ointments, sunscreens and sunblock's, moisturizers and emollients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.